<DOC>
	<DOC>NCT03067441</DOC>
	<brief_summary>The purpose of this study is to see if bempedoic acid (ETC-1002) is safe and well-tolerated in patients with high cardiovascular risk and elevated LDL cholesterol that is not adequately controlled by their current therapy.</brief_summary>
	<brief_title>Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Successfully completed CLEAR Harmony (1002040) parent study Experienced a treatmentrelated SAE that led to study drug discontinuation in the CLEAR Harmony (1002040) parent study. Medical condition requires lipid measurement and/or adjustment of background lipidregulating therapy.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>hyperlipidemia</keyword>
	<keyword>cholesterol</keyword>
	<keyword>heterozygous familial hypercholesterolemia</keyword>
	<keyword>atherosclerotic cardiovascular disease</keyword>
	<keyword>ASCVD</keyword>
	<keyword>HeFH</keyword>
	<keyword>LDL</keyword>
</DOC>